Forte Biosciences, Inc. (FBRX) Profit Margin
Forte Biosciences, Inc. (FBRX) net profit margin by fiscal period. Analyze profit margins in Excel with MarketXLS.
Profit Margin Data
| Period | Net Profit Margin |
|---|---|
| 2017-12-31 | -95031.71% |
| 2018-12-31 | -271.37% |
| 2019-12-31 | -11302.78% |
| 2020-12-31 | N/A |
| 2021-12-31 | N/A |
| 2022-12-31 | N/A |
| 2023-12-31 | N/A |
| 2024-12-31 | N/A |
| 2025-12-31 | N/A |
How FBRX compares with sector peers
| Symbol | Company | Net profit margin (latest fiscal year) |
|---|---|---|
| ACRS | Aclaris Therapeutics Inc. | -829.58% |
| MNOV | MediciNova Inc. | -2928.78% |
| RFL | Rafael Holdings Inc. Class B | -3328.24% |
| VTGN | Vistagen Therapeutics Inc. | -5491.33% |
| PLSE | Pulse Biosciences Inc | -20794.57% |
These are five companies in the same sector as FBRX with a comparable annual net profit margin. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Forte Biosciences, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Profit_Margin("FBRX", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | FBRX | $76.89 | -0.01% | 3.20M |
| 3 | ||||
| 4 | ||||
| 5 |